The Uncoupling Protein 2 Ala55Val Polymorphism
Is Associated with Diabetes Mellitus:
The CARDIA Study
Xinhua Yu,
1
David R. Jacobs, Jr.,
1,2*
Pamela J. Schreiner,
1
Myron D. Gross,
3
Michael W. Steffes,
3
and Myriam Fornage
4
Background: Uncoupling proteins (UCPs) reduce ATP
generation with concomitant increased release of heat.
The activities of UCPs have been related to obesity and
energy metabolism.
Methods: We investigated the association of the com-
monly observed UCP2 Ala55Val (V) polymorphism
with diabetes mellitus and impaired fasting glucose
(IFG) among 3684 participants in the Coronary Artery
Risk Development in Young Adults (CARDIA) study.
Results: The V frequency was 45% in blacks and 42%
in whites. Those with the Val/Val (VV) genotype had a
higher incidence of diabetes than those having the
Ala/Ala (AA) genotype (5.8% vs 3.3%; P 0.02). Simi-
larly, the incidences of diabetes in participants without
abdominal obesity were 2.8% and 1.0% (P 0.03) in the
VV and AA groups, and 12.4% and 8.3% (P 0.15) in
participants with abdominal obesity. The incidence of
IFG was higher in VV vs AA only in those without
abdominal obesity (12.9% vs 9.2%). These trends per-
sisted in minimally and fully adjusted models, and in
strata of blacks and whites and men and women. The
homeostasis model assessment for insulin resistance
was highest in VV in the combined group of those with
IFG or untreated diabetes, but not in those with normal
fasting glucose.
Conclusion: The VV genotype of the UCP2 polymor-
phism was positively related to diabetes. It may involve
increased insulin resistance in those with impaired
glucose homeostasis.
© 2005 American Association for Clinical Chemistry
The etiology of type 2 diabetes relates to peripheral
insulin resistance and a decrease in insulin secretion. In
addition, it involves multiple dietary, hormonal, biochem-
ical, and genetic factors, many of which are associated
with obesity and may reflect energy usage and metabolic
efficiency.
Uncoupling proteins (UCPs)
5
comprise a complex of
several related proteins that may significantly regulate
energy utilization. UCP, as a proton transporter, uncou-
ples the proton-motive force (diminishing the proton
gradient across the inner mitochondrial membrane), de-
creasing formation of both ATP and reactive oxygen
species (ROS) with the release of chemical energy as heat.
UCP2, one of 5 known human homologs (1, 2 ), is located
on chromosome 11 (1), a site linked to lower resting
metabolic rate (3). Work in model systems and in animals
suggests that increased expression of UCP2 decreases
glucose-stimulated insulin secretion and thus impairs
glucose homeostasis and increases the risk of diabetes
mellitus (4–6). In contrast, elimination of the UCP2 gene
in diabetes-prone rodents decreases the risk of diabetes
(7).
Variation in UCP activity may influence the production
of ATP and ROS in humans. A common UCP2 polymor-
phism involves a C-to-T substitution in exon 4 at position
1
Division of Epidemiology, School of Public Health, University of Minne-
sota, Minneapolis, MN.
2
Department of Nutrition, University of Oslo, Oslo, Norway.
3
Department of Laboratory Medicine, Medical School, University of
Minnesota, Minneapolis, MN.
4
Institute of Molecular Medicine, University of Texas Health Science
Center at Houston, Houston, TX.
*Address correspondence to this author at: University of Minnesota,
Division of Epidemiology, School of Public Health, 1300 South 2nd St., Suite
300, Minneapolis, MN 55454. Fax 612-624-0315; e-mail jacobs@epi.umn.edu.
Received November 3, 2004; accepted May 20, 2005.
Previously published online at DOI: 10.1373/clinchem.2004.044859
5
Nonstandard abbreviations: UCP, uncoupling protein; ROS, reactive
oxygen species; CARDIA, Coronary Artery Risk Development in Young
Adults study; BMI, body mass index; FAM, 6-carboxyfluorescein; TAMRA,
6-carboxytetramethylrhodamine; IFG, impaired fasting glucose; HOMA, ho-
meostasis model assessment; OR, odds ratio; and NFG, normal fasting glucose.
Clinical Chemistry 51:8
1451–1456 (2005)
Lipids, Lipoproteins,
and Cardiovascular
Risk Factors
1451
Downloaded from https://academic.oup.com/clinchem/article/51/8/1451/5629922 by guest on 11 June 2022